We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
GTCR portfolio company Corza Health has completed the acquisition of US-based medical technology firm Surgical Specialties from a consortium led by ZQ Capital and Vivo Capital. The consortium,
Roche has secured CE mark approval for its new SARS-CoV-2 Rapid Antigen Test Nasal, which enables self-collection of specimens by patients. The company will start supplying the new
Medical technology company Hologic has entered into a multi-year strategic collaboration with Google Cloud to advance next-generation digital diagnostic capabilities. Under the deal, Google Cloud’s machine learning (ML)
South Korean biotechnology company Seegene has developed the Allplex SARS-CoV-2 Variants Ⅰ Assay, which is claimed to be the world’s first Covid-19 diagnostic variant test. The Allplex SARS-CoV-2
Medtronic has secured approval from the US Food and Drug Administration (FDA) for its DiamondTemp ablation (DTA) system to treat atrial fibrillation. Designed to provide radiofrequency (RF) energy
Edwards Lifesciences announced that its RESILIA tissue aortic valve has shown favourable safety and efficacy at five years in the COMMENCE clinical trial. The trial showed that the
Synergy Disc Replacement (SDRi) has recruited the first patient in its US investigational device exemption (IDE) clinical study of artificial cervical disc technology named the Synergy Disc. The
Medical technology company Hillrom has purchased contact-free continuous monitoring technology from EarlySense for a cash consideration of $30m. The deal also includes the potential payments based on the
Biotechnology company Cardio Diagnostics has introduced a new heart disease risk assessment test called Epi+Gen CHD. Epi+Gen CHD test has been developed to sensitively evaluate the risk for
Neurotechnology company Neurolief has signed an exclusive agreement with Sawai Pharmaceutical to develop and market a brain neuromodulation device called Relivion in Japan. Relivion is a non-invasive digital